What is Immunome's change in deferred revenue?

Immunome (IMNM) reported change in deferred revenue of -$0 in Q1 2026.

How has Immunome's change in deferred revenue changed year-over-year?

Immunome's change in deferred revenue increased by 100.0% year-over-year, from -$2.93M to -$0.

What does change in deferred revenue mean?

Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.

Immunome IMNM Change in Deferred Revenue

Change in Deferred Revenue at other companies

Arcus BiosciencesRCUS

-$17M+39.3%

IDEAYA Biosciences, Inc.IDYA

-$587K—

Adaptive BiotechnologiesADPT

$4M+220%

CRISPR TherapeuticsCRSP

-$427K+48.2%

Crinetics PharmaceuticalsCRNX

-$428K-18.6%

Kymera TherapeuticsKYMR

-$34.37M-1,536%

Other financials

Income statement

See full

Revenue--100%

Operating income-$59.3M-32.9%

Net income-$53.8M-29.3%

EPS (diluted)-$0.48+7.7%

Balance sheet

See full

Cash & equivalents$582.7M+126%

Total debt$3.7M-22.6%

Total equity$588.7M+91.7%

Total assets$619.8M+80.9%

Cash flow

See full

Operating cash flow-$58.6M-10.5%

CapEx$3.0M-18.1%

Free cash flow-$61.6M-8.7%

Valuation

See full

Market cap$2.19B+323%

Enterprise value$1.61B+470%

P/S545.2×+498×

Profitability

See full

Operating margin-5,947.9%-12,002pp

Net margin-5,593.8%-11,284pp

FCF margin-5,118.9%-8,601pp

Returns & leverage

See full

Return on equity-50.1%-10.8pp

Debt / equity0×0.0×

Current ratio21.7×+11.2×

Where this comes from

Reported directly by Immunome in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunome's change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunome's change in deferred revenue?: Immunome (IMNM) reported change in deferred revenue of -$0 in Q1 2026.
How has Immunome's change in deferred revenue changed year-over-year?: Immunome's change in deferred revenue increased by 100.0% year-over-year, from -$2.93M to -$0.
What does change in deferred revenue mean?: Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.